Phibro Animal Health (PAHC) Misses Q1 EPS by 5c, Revenues Miss; Reaffirms Previous FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health Corporation Reports First Quarter Results
November 4, 2019 4:45 PM ESTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its first quarter ended September 30, 2019.
Highlights for the September 2019 quarter (compared to the September 2018 quarter)
Net sales of $190 million, a decrease of $10 million, or 5% Net income of $3 million, a decrease of $14 million, or 85% Diluted EPS of $0.06, a decrease of $0.34, or 85% Adjusted EBITDA of $20 million, a decrease of $10 million, or 35% Adjusted diluted EPS of $0.19, a decrease of $0.20, or... More


